review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1036182255 |
P356 | DOI | 10.1007/BF00191216 |
P698 | PubMed publication ID | 9116754 |
P2093 | author name string | M Liebert | |
P2860 | cites work | Subnormal concentrations of urinary epidermal growth factor in patients with kidney disease | Q68797034 |
Differential effects of epidermal growth factor (EGF) on cell locomotion and cell proliferation in a cloned human embryonal carcinoma-derived cell line in vitro | Q68829391 | ||
Immunohistochemical localization of the epidermal growth factor receptor in normal human tissues | Q68912114 | ||
Tumor necrosis factor increases the number of epidermal growth factor receptors on human fibroblasts | Q68936080 | ||
The TGF-alpha precursor expressed on the cell surface binds to the EGF receptor on adjacent cells, leading to signal transduction | Q69052663 | ||
Epidermal growth factor receptor in human bladder cancer: a comparison of immunohistochemistry and ligand binding | Q69735943 | ||
Characterization and quantitation of the epidermal growth factor receptor in invasive and superficial bladder tumors | Q69746810 | ||
Imaging of human tumor xenografts with an indium-111-labeled anti-epidermal growth factor receptor monoclonal antibody | Q69755368 | ||
Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours | Q69856767 | ||
Epidermal growth factor promotes the chemotactic migration of cultured rat intestinal epithelial cells | Q69873417 | ||
Transferrin receptor expression and the control of cell growth | Q70160606 | ||
Flow cytometry in comparison with mitotic index in predicting disease outcome in transitional-cell bladder cancer | Q70519925 | ||
Elevated levels of the angiogenic peptide basic fibroblast growth factor in urine of bladder cancer patients | Q70537350 | ||
An essential heparin-binding domain in the fibroblast growth factor receptor kinase | Q70619107 | ||
A recombinant form of Pseudomonas exotoxin A containing transforming growth factor alpha near its carboxyl terminus for the treatment of bladder cancer | Q70736838 | ||
Insulin-like growth factor binding protein 1 expression inhibits insulin-like growth factor I action in MCF-7 breast cancer cells | Q71613317 | ||
Interrelationship between expression of p53, proliferating cell nuclear antigen and c-erbB-2 in bladder cancer | Q72236542 | ||
Insulin-like growth factors | Q72544380 | ||
Proliferative state of the urothelium with benign and atypical changes. Correlation with transferrin and epidermal growth factor receptors and blood group antigens | Q72577693 | ||
Evidence for the potentiation of epidermal growth factor receptor tyrosine kinase activity by association with the detergent-insoluble cellular cytoskeleton: analysis of intact and carboxy-terminally truncated receptors | Q72614941 | ||
Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells | Q72645182 | ||
Expression of c-erbB-2 protein in normal and neoplastic urothelium: lack of adverse prognostic effect in human urinary bladder cancer | Q72689176 | ||
Pharmaceutical research in molecular oncology | Q72790769 | ||
Alterations in phenotypic biochemical markers in bladder epithelium during tumorigenesis | Q23922988 | ||
Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants | Q24308772 | ||
The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling | Q24337017 | ||
Signal transduction by receptors with tyrosine kinase activity | Q27860624 | ||
Receptors for the TGF-β family | Q28210923 | ||
The transforming growth factor-beta family | Q29615948 | ||
Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells | Q29616544 | ||
Growth factor signaling by receptor tyrosine kinases | Q29618315 | ||
Identical splicing of aberrant epidermal growth factor receptor transcripts from amplified rearranged genes in human glioblastomas | Q33881165 | ||
Receptors for epidermal growth factor and other polypeptide mitogens | Q34163558 | ||
Signalling by receptor tyrosine kinases | Q34306539 | ||
The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms | Q34349039 | ||
Peptide growth factors and inflammation, tissue repair, and cancer | Q34531790 | ||
Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction | Q35229509 | ||
Epidermal growth factor receptor and bladder cancer: a review | Q35268041 | ||
Receptor tyrosine kinase substrates: src homology domains and signal transduction | Q35344982 | ||
Reduced expression of TGF beta is associated with advanced disease in transitional cell carcinoma | Q35976124 | ||
Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis | Q35979121 | ||
Epidermal growth factor--interactions with normal and malignant urothelium: in vivo and in situ studies | Q42521138 | ||
Significance of erbB-2 gene product as a target molecule for cancer therapy | Q42799398 | ||
Increased levels of fibroblast growth factor-like activity in urine from patients with bladder or kidney cancer | Q42804162 | ||
Epidermal growth factor and transforming growth factor-alpha induce differential processing of the epidermal growth factor receptor | Q42833585 | ||
Epidermal growth factor-induced truncation of the epidermal growth factor receptor | Q42835084 | ||
Recycling of epidermal growth factor-receptor complexes in A431 cells: identification of dual pathways | Q43107632 | ||
Differential expression of a Mr approximately 90,000 cell surface transferrin receptor-related glycoprotein on murine B16 metastatic melanoma sublines selected for enhanced brain or ovary colonization. | Q44268717 | ||
Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer | Q45274822 | ||
Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma | Q45286409 | ||
Transmembrane TGF-alpha precursors activate EGF/TGF-alpha receptors. | Q45931354 | ||
Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer | Q46320350 | ||
The human transferrin receptor gene: genomic organization, and the complete primary structure of the receptor deduced from a cDNA sequence | Q48385617 | ||
Effect of epidermal growth factor on membrane motility and cell locomotion in cultures of human clonal glioma cells | Q53437421 | ||
Amplification and expression of the c-erb B-2/neu proto-oncogene in human bladder cancer. | Q53511518 | ||
The epidermal growth factor receptor and the prognosis of bladder cancer. | Q53797133 | ||
In vitro Sensitivity Testing of Human Bladder Cancers and Cell Lines to TP-40, a Hybrid Protein with selective Targeting and Cytotoxicity | Q62267749 | ||
Increased immunodetection of acidic fibroblast growth factor in bladder cancer, detectable in urine | Q63966550 | ||
An immunohistologic evaluation of C-erbB-2 gene product in patients with urinary bladder carcinoma | Q67522705 | ||
aFGF Content Increases with Malignancy in Human Chondrosarcoma and Bladder Cancer | Q67709845 | ||
The role of microfilaments in the capping of epidermal growth factor receptor in A431 cells | Q67986179 | ||
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells | Q68201732 | ||
Transferrin receptor expression by human bladder transitional cell carcinomas | Q68223047 | ||
Transforming growth factor beta 1 inhibits epidermal growth factor receptor endocytosis and down-regulation in cultured fetal rat hepatocytes | Q68244964 | ||
Interaction of basic fibroblast growth factor with extracellular matrix and receptors | Q68273440 | ||
Lymphoscintigraphy with 13I-labelled epidermal growth factor | Q68291982 | ||
Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors | Q68748541 | ||
Transferrin receptor expression in primary superficial human bladder tumours identifies patients who develop recurrences | Q68786449 | ||
Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder | Q35984818 | ||
Increased epidermal growth factor receptor gene expression by gamma-interferon in a human breast carcinoma cell line | Q35992885 | ||
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts | Q36198091 | ||
Calcium signals in growth factor signal transduction. | Q36205896 | ||
Down regulation of epidermal growth factor receptors: direct demonstration of receptor degradation in human fibroblasts | Q36210313 | ||
Cell movement elicited by epidermal growth factor receptor requires kinase and autophosphorylation but is separable from mitogenesis | Q36233701 | ||
Receptor tyrosine kinase signaling required for integrin alpha v beta 5-directed cell motility but not adhesion on vitronectin | Q36234780 | ||
Epidermal growth factor receptor-mediated cell motility: phospholipase C activity is required, but mitogen-activated protein kinase activity is not sufficient for induced cell movement | Q36234800 | ||
Signal transduction via the MAP kinases: proceed at your own RSK. | Q36381460 | ||
Transforming growth factors produced by certain human tumor cells: polypeptides that interact with epidermal growth factor receptors | Q36405679 | ||
A dual receptor system is required for basic fibroblast growth factor activity | Q36428185 | ||
Sequestration and release of basic fibroblast growth factor | Q36463376 | ||
Regulators and Effectors of ras Proteins | Q36467146 | ||
Gene amplification and overexpression of EGF receptor in squamous cell carcinomas of the head and neck | Q36467548 | ||
Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors | Q36787477 | ||
Biological Activities of Fibroblast Growth Factors | Q36940855 | ||
Structure, function and transforming potential of the epidermal growth factor receptor | Q37936898 | ||
Transforming growth factor-alpha. A model for membrane-anchored growth factors. | Q38006301 | ||
Autocrine regulation of cell growth and transformation by basic fibroblast growth factor | Q38037837 | ||
Phenotypic and cytogenetic characterization of human bladder urothelia expanded in vitro. | Q38575583 | ||
Transforming growth factor alpha | Q39517957 | ||
Transforming growth factor-alpha: structure and biological activities | Q39754902 | ||
Angiogenesis and colonization in the tumor metastatic process: basic and applied advances | Q40388392 | ||
Role of Insulin‐like Growth Factor Binding Proteins in Modifying IGF Actionsa | Q40491193 | ||
Epidermal growth factor-related peptides in the pathogenesis of human breast cancer. | Q40623950 | ||
The neu-oncogene: signal transduction pathways, transformation mechanisms and evolving therapies | Q40624402 | ||
Targeted toxins as anticancer agents | Q40624536 | ||
Gene therapy through signal transduction pathways and angiogenic growth factors as therapeutic targets in breast cancer. | Q40676742 | ||
The ins and outs of fibroblast growth factors | Q40694270 | ||
Epidermal Growth Factor (Urogastrone) in Human Fluids: Size Heterogeneity* | Q40706441 | ||
Oncogene regulation by growth factors | Q40728904 | ||
Homologous Radioimmunoassay for Human Epidermal Growth Factor (Urogastrone)* | Q40740683 | ||
How receptor tyrosine kinases activate Ras. | Q40778358 | ||
Transforming growth factor beta and the cell surface in tumor progression | Q40801234 | ||
EGF receptor in neoplasia and metastasis | Q40801239 | ||
Membrane-anchored growth factors. | Q40856819 | ||
Phylogeny of the insulin-like growth factors (IGFs) and receptors: a molecular approach | Q40858628 | ||
Molecular dynamics of insulin/IGF-I receptor transmembrane signaling | Q40858632 | ||
Growth factors: regulation of normal and neoplastic growth | Q40882275 | ||
Evaluation of epidermal growth factor receptors in bladder tumours | Q41153245 | ||
Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line | Q41556505 | ||
Characterization of insulin-like growth factor I binding sites in human bladder cancer cell lines | Q41580263 | ||
Immunohistochemical detection of acidic fibroblast growth factor in bladder transitional cell carcinoma | Q41648912 | ||
Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells | Q41669431 | ||
The expression of epidermal growth factor receptor on human bladder cancer: potential use in radioimmunoscintigraphy | Q41675811 | ||
Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity. | Q41758565 | ||
Expression of c-erbB-2 gene product in urinary bladder cancer | Q41898078 | ||
Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors | Q42054821 | ||
Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder | Q42382564 | ||
Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts | Q42453725 | ||
Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma | Q42465267 | ||
Transferrin receptor activity as a marker in transitional cell carcinoma of the bladder | Q42475744 | ||
P433 | issue | 6 | |
P304 | page(s) | 349-355 | |
P577 | publication date | 1995-01-01 | |
P1433 | published in | World Journal of Urology | Q15750774 |
P1476 | title | Growth factors in bladder cancer | |
P478 | volume | 13 |
Search more.